Evidence map›Paper›PMID 28115618›Full record

ArticlePhilosophical transactions. Series A, Mathematical, physical, and engineering sciences2017

Tumour chemotherapy strategy based on impulse control theory.

Hai-Peng Ren, Yan Yang, Murilo S Baptista, Celso Grebogi

Abstract read
In one paragraph

Article in Philosophical transactions. Series A, Mathematical, physical, and engineering sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Horizons of cybernetical physics.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hai-Peng RenShaanxi Key Laboratory of CSCIIP, Xi'an University of Technology, Xi'an 710048, People's Republic of China renhaipeng@xaut.edu.cn.ORCID http://orcid.org/0000-0003-3834-5103
Yan YangShaanxi Key Laboratory of CSCIIP, Xi'an University of Technology, Xi'an 710048, People's Republic of China.
Murilo S BaptistaInstitute for Complex Systems and Mathematical Biology, University of Aberdeen, Aberdeen AB24 3UE, UK.
Celso GrebogiInstitute for Complex Systems and Mathematical Biology, University of Aberdeen, Aberdeen AB24 3UE, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemotherapy is a widely accepted method for tumour treatment. A medical doctor usually treats patients periodically with an amount of drug according to empirical medicine guides. From the point of view of cybernetics, this procedure is an impulse control system, where the amount and frequency of drug used can be determined analytically using the impulse control theory. In this paper, the stability of a chemotherapy treatment of a tumour is analysed applying the impulse control theory. The globally stable condition for prescription of a periodic oscillatory chemotherapeutic agent is derived. The permanence of the solution of the treatment process is verified using the Lyapunov function and the comparison theorem. Finally, we provide the values for the strength and the time interval that the chemotherapeutic agent needs to be applied such that the proposed impulse chemotherapy can eliminate the tumour cells and preserve the immune cells. The results given in the paper provide an analytical formula to guide medical doctors to choose the theoretical minimum amount of drug to treat the cancer and prevent harming the patients because of over-treating.This article is part of the themed issue 'Horizons of cybernetical physics'.

Indexed as

Models, BiologicalCell ProliferationNeoplasmsboundednesschemotherapyimpulse control systempermanencestability

Identifiers

PMID28115618
PMCPMC5311440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.